Null Compliance Security

Null Compliance Security

From here

Null Compliance Security, or NCS, was an experimental prison security level. NCS was a joint effort between pharmaceutical giant Pfizer, twelve participating state behavioral facilities, Harvard Medical School, and Stanford University School of Medicine. USP Florence ADMAX was elected as the corrections facility that would hold the first Null Compliance Security prison. The NCS was built in 1997 as an added wing to the maximum security prison. In the Null Compliance prison, with the use of eight medications, and therapeutic stimulation, prisoners are rehabilitated to nearly completely non-violent behavior, without the use of sedatives. Prisoners are carefully monitored and are helped by nurses and prison staff with day-to-day activities. Prisoners are kept on the medication and therapeutic stimulation to maintain their acceptable behavior for 40 days. Afterward, complete behavioral shifts are permanent after 40-50 days. Prisoners then become Null Patients, where they are kept under federal care as mental defects.

After ten years and handling 845 prisoners, the NCS prison wing was closed in 2007. Null Patients remain under federal care.